Reach Us +44-1625-708989
Evaluation And Management Of Resistant Hypertension | 9172
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Evaluation and management of resistant hypertension

2nd International Conference on Nephrology & Therapeutics

Ajay Srivastava

Accepted Abstracts: J Nephrol Therapeutic

DOI: 10.4172/2161-0959.S1.011

R esistant hypertension is a significant clinical problem faced by not only the primary care physician, but specialists as well. Nonetheless, the evaluation and management between and amongst these groups can be quite variable. Given that the etiology is many times multifactorial, and that evaluation must include consideration of pseudoresistance and inadequate treatment regimens, the management can be intricate. As such, this presentation will attempt to provide an algorithm for the evaluation and management of resistant hypertension in the context of available data.
Ajay Srivastava completed his M.D. at the University of Texas Medical Branch and his subsequent residency training in Internal Medicine and fellowship in Nephrology at the University of Rochester Medical Center. He is an Assistant Professor of Medicine and Chief of the Division of Nephrology at Mercer University School of Medicine
Relevant Topics